ANNX short interest
Annexon Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 32,009,914 |
|---|---|
| Change vs prior report | -862,081 (-2.6%) |
| Change over six months | +71.8% |
| Days to cover | 8.90 (sector: 3.78) |
| Average daily volume | 3,597,520 |
| Rank in Healthcare | #153 of 922 by days to cover |
ANNX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 32,009,914 | -2.6% | 8.90 | 3,597,520 |
| 2026-09-15 | 32,871,995 | +2.4% | 11.68 | 2,813,644 |
| 2026-08-31 | 32,094,286 | -1.5% | 12.72 | 2,524,025 |
| 2026-08-14 | 32,583,299 | +5.9% | 13.17 | 2,474,096 |
| 2026-07-31 | 30,772,146 | +3.2% | 10.45 | 2,944,760 |
| 2026-07-15 | 29,827,889 | +0.8% | 5.74 | 5,194,732 |
| 2026-06-30 | 29,604,763 | +12.2% | 5.42 | 5,460,764 |
| 2026-06-15 | 26,388,542 | +2.1% | 9.30 | 2,836,987 |
| 2026-05-29 | 25,834,304 | +6.4% | 9.73 | 2,654,616 |
| 2026-05-15 | 24,288,025 | +3.6% | 13.28 | 1,828,637 |
| 2026-04-30 | 23,443,455 | +19.1% | 10.91 | 2,148,863 |
| 2026-04-15 | 19,675,024 | +5.6% | 7.87 | 2,498,716 |
| 2026-03-31 | 18,637,378 | +13.6% | 5.72 | 3,258,014 |
| 2026-03-13 | 16,401,412 | +3.1% | 6.11 | 2,682,175 |
| 2026-02-27 | 15,901,379 | -1.4% | 6.99 | 2,274,965 |
| 2026-02-13 | 16,131,493 | -6.3% | 7.76 | 2,077,900 |
| 2026-01-30 | 17,217,855 | -6.6% | 7.66 | 2,249,084 |
| 2026-01-15 | 18,436,024 | +13.2% | 6.13 | 3,007,528 |
| 2025-12-31 | 16,284,598 | +33.4% | 5.98 | 2,721,550 |
| 2025-12-15 | 12,204,357 | +16.2% | 4.34 | 2,809,921 |
| 2025-11-28 | 10,504,723 | +20.3% | 2.35 | 4,468,060 |
| 2025-11-14 | 8,731,864 | -4.6% | 4.53 | 1,926,347 |
| 2025-10-31 | 9,151,927 | -10.2% | 4.39 | 2,086,561 |
| 2025-10-15 | 10,188,623 | +0.1% | 6.33 | 1,609,579 |
| 2025-09-30 | 10,178,665 | +6.4% | 3.85 | 2,640,582 |
import finzdata as yf
yf.Ticker("ANNX").short_interest # every report since 2017
yf.Client().short_interest(["ANNX"], start="2018-01-01")Healthcare short interest · ANNX price history · Who owns ANNX · All short interest